Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
VRTX
|
Yuchun Lee
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 34.04% |
$163,080
$81.54 p/Share
|
Apr 04
2022 |
|
VRTX
|
Bastiano Sanna
EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct | 562 Reduced 1.19% |
$150,481
$267.76 p/Share
|
Apr 04
2022 |
|
CPPTL
|
Silver Point Capital L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 0.19% |
$406,250
$16.25 p/Share
|
Apr 04
2022 |
|
QS
|
Kevin Hettrich
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 46,285 Reduced 7.87% |
$989,573
$21.38 p/Share
|
Apr 04
2022 |
|
QS
|
Kevin Hettrich
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 46,285 Added 7.29% |
$60,633
$1.31 p/Share
|
Apr 04
2022 |
|
CPSS
|
Black Diamond Capital Management, L.L.C.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 16,284 Added 0.35% |
$174,727
$10.73 p/Share
|
Apr 04
2022 |
|
QRHC
|
Wynnefield Partners Small Cap Value LP I
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,775 Added 0.3% |
$23,178
$6.14 p/Share
|
Apr 04
2022 |
|
QRHC
|
Wynnefield Partners Small Cap Value LP I
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 3,596 Added 0.33% |
$22,079
$6.14 p/Share
|
Apr 04
2022 |
|
MDVL
|
Abg Wtt Med Avail LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 14,117,646 Added 38.06% |
$14,964,704
$1.06 p/Share
|
Apr 04
2022 |
|
SKIL
|
Naspers LTD
Director |
BUY
Other acquisition or disposition
|
Indirect | 11,250,228 Added 15.52% |
-
|
Apr 04
2022 |
|
STRY
|
Tiger Global Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 390,500 Reduced 1.89% |
$3,377,825
$8.65 p/Share
|
Apr 04
2022 |
|
SXT
|
Winder Investment Pte LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 23,659 Added 0.22% |
$2,032,781
$85.92 p/Share
|
Apr 04
2022 |
|
THFF
|
Susan M Jensen |
BUY
Open market or private purchase
|
Direct | 40 Added 7.14% |
$1,709
$42.72 p/Share
|
Apr 04
2022 |
|
CVS
|
Daniel P Finke
EVP/Pres, Health Care Benefits |
SELL
Open market or private sale
|
Direct | 55,359 Reduced 59.24% |
$5,543,097
$100.13 p/Share
|
Apr 04
2022 |
|
CVS
|
Daniel P Finke
EVP/Pres, Health Care Benefits |
BUY
Exercise of conversion of derivative security
|
Direct | 43,327 Added 35.92% |
$2,437,577
$56.26 p/Share
|
Apr 04
2022 |
|
AVGO
|
Diane M Bryant
Director |
BUY
Grant, award, or other acquisition
|
Direct | 413 Added 16.86% |
-
|
Apr 04
2022 |
|
AVGO
|
Gayla J Delly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 413 Added 10.65% |
-
|
Apr 04
2022 |
|
AVGO
|
Raul J Fernandez
Director |
BUY
Grant, award, or other acquisition
|
Direct | 413 Added 11.68% |
-
|
Apr 04
2022 |
|
AVGO
|
Eddy W Hartenstein
Director |
BUY
Grant, award, or other acquisition
|
Direct | 413 Added 31.72% |
-
|
Apr 04
2022 |
|
AVGO
|
Check Kian Low
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 18 Reduced 0.39% |
$11,427
$634.85 p/Share
|
Apr 04
2022 |
|
AVGO
|
Check Kian Low
Director |
BUY
Grant, award, or other acquisition
|
Direct | 413 Added 8.24% |
-
|
Apr 04
2022 |
|
AVGO
|
Justine Page
Director |
BUY
Grant, award, or other acquisition
|
Direct | 413 Added 11.59% |
-
|
Apr 04
2022 |
|
AVGO
|
Harry L. You
Director |
BUY
Grant, award, or other acquisition
|
Direct | 413 Added 16.35% |
-
|
Apr 04
2022 |
|
VZ
|
Craig L. Silliman
EVP&Pres.-VZ Global Services |
SELL
Open market or private sale
|
Direct | 1,558 Reduced 3.93% |
$81,016
$52.0 p/Share
|
Apr 04
2022 |
|
HPQ
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 4,391,884 Added 3.7% |
$159,996,335
$36.43 p/Share
|
Apr 04
2022 |
|
ARES
|
Michael J Arougheti
Co-Founder and CEO |
SELL
Open market or private sale
|
Indirect | 26,879 Reduced 5.38% |
$2,286,328
$85.06 p/Share
|
Apr 04
2022 |
|
RKT
|
Jay Farner
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 8,600 Added 0.56% |
$99,072
$11.52 p/Share
|
Apr 04
2022 |
|
PLNT
|
Enshalla Anderson |
BUY
Grant, award, or other acquisition
|
Direct | 183 Added 4.45% |
-
|
Apr 04
2022 |
|
PLNT
|
Christopher Tanco |
BUY
Grant, award, or other acquisition
|
Direct | 185 Added 6.14% |
-
|
Apr 04
2022 |
|
PLNT
|
Frances G Rathke |
BUY
Grant, award, or other acquisition
|
Direct | 192 Added 1.22% |
-
|
Apr 04
2022 |
|
PLNT
|
Cambria W Dunaway |
BUY
Grant, award, or other acquisition
|
Direct | 192 Added 1.57% |
-
|
Apr 04
2022 |
|
PLNT
|
Stephen Spinelli Jr |
BUY
Grant, award, or other acquisition
|
Direct | 325 Added 1.88% |
-
|
Apr 04
2022 |
|
SQ
|
Amrita Ahuja
CFO & COO |
SELL
Open market or private sale
|
Direct | 2,680 Reduced 2.16% |
$379,997
$141.79 p/Share
|
Apr 04
2022 |
|
SQ
|
Brian Grassadonia
Ecosystem Lead |
SELL
Open market or private sale
|
Direct | 5,051 Reduced 3.62% |
$716,181
$141.79 p/Share
|
Apr 04
2022 |
|
CRNX
|
Stephen F. Betz
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 7.17% |
$215,730
$23.97 p/Share
|
Apr 04
2022 |
|
MDVL
|
Redmile Group, LLC
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 14,117,646 Added 35.91% |
$14,964,704
$1.06 p/Share
|
Apr 04
2022 |
|
RBOT
|
Philip Liang
Director |
BUY
Other acquisition or disposition
|
Direct | 1,007,100 Added 43.49% |
-
|
Apr 04
2022 |
|
RBOT
|
Philip Liang
Director |
SELL
Other acquisition or disposition
|
Indirect | 1,197,748 Reduced 58.32% |
-
|
Apr 04
2022 |
|
KTOS
|
Eric M Demarco
President & CEO |
SELL
Payment of exercise price or tax liability
|
Indirect | 58,287 Reduced 5.23% |
$1,087,053
$18.65 p/Share
|
Apr 04
2022 |
|
BBY
|
Mario Jesus Marte
Director |
SELL
Open market or private sale
|
Indirect | 8 Reduced 100.0% |
$755
$94.34 p/Share
|
Apr 04
2022 |
|
UNIT
|
Kenny Gunderman
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 272,694 Added 20.06% |
-
|
Apr 04
2022 |
|
UNIT
|
Kenny Gunderman
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 147,460 Reduced 13.57% |
$2,042,321
$13.85 p/Share
|
Apr 04
2022 |
|
SIEN
|
Oliver Christian Bennett
GC & Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 7,229 Reduced 2.81% |
$15,687
$2.17 p/Share
|
Apr 04
2022 |
|
SIEN
|
Oliver Christian Bennett
GC & Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct | 15,000 Added 5.62% |
-
|
Apr 04
2022 |
|
GNCA
|
Girish N Aakalu
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 963 Reduced 1.28% |
$1,204
$1.25 p/Share
|
Apr 04
2022 |
|
GNCA
|
William D Clark
President and CEO |
SELL
Open market or private sale
|
Direct | 3,924 Reduced 1.05% |
$4,905
$1.25 p/Share
|
Apr 04
2022 |
|
GNCA
|
Thomas Andrew Davis
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,091 Reduced 1.57% |
$1,364
$1.25 p/Share
|
Apr 04
2022 |
|
GNCA
|
Diantha Duvall
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 963 Reduced 1.04% |
$1,204
$1.25 p/Share
|
Apr 04
2022 |
|
GNCA
|
Jessica Baker Flechtner
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 1,212 Reduced 1.24% |
$1,515
$1.25 p/Share
|
Apr 04
2022 |
|
DYNT
|
Norman Roegner Iii
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,612 Added 14.78% |
$1,177
$0.73 p/Share
|
Apr 04
2022 |